Early research (Phase 1)Study completedNCT03580278What this trial is testingInvestigate the Safety, Tolerability, Pharmacokinetic, and Efficacy of ABY-035/AFO2Who this might be right forPsoriasis Affibody 33
Testing effectiveness (Phase 2)Study completedNCT01462643What this trial is testingEfficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque TestWho this might be right forPsoriasis Almirall, S.A. 22
Not applicableNot Yet RecruitingNCT06802848What this trial is testingReal-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)Who this might be right forPlaque PsoriasisPsoriatic ArthritisScalp Psoriasis+3 more Chongqing Genrix Biopharmaceutical Co., Ltd 1,000
Not applicableStudy completedNCT01090063What this trial is testingEfficacy and Safety of Ustekinumab in Patients With Moderate to Severe Palmar Plantar PsoriasisWho this might be right forModerate to Severe Palmar Plantar Psoriasis Tufts Medical Center 26
Not applicableUnknownNCT02122978What this trial is testingComparing Mindfulness Based Cognitive Therapy and Mindfulness Based Self-compassion Therapy in a Psoriasis SampleWho this might be right forPsoriasis St Vincent's University Hospital, Ireland 94
Large-scale testing (Phase 3)Study completedNCT06088043What this trial is testingA Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of TreatmentWho this might be right forPlaque Psoriasis Takeda 693
Early research (Phase 1)Study completedNCT07051538What this trial is testingA Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque PsoriasisWho this might be right forModerate to Severe Plaque Psoriasis Guangdong Hengrui Pharmaceutical Co., Ltd 64
Early research (Phase 1)Study completedNCT01899755What this trial is testingEvaluate the Pharmacokinetics (PK), Safety and Tolerability, Immunogenicity, and Pharmacodynamics (PD) of GSK2800528 in Healthy Subjects.Who this might be right forPsoriasis GlaxoSmithKline 45
Large-scale testing (Phase 3)Study completedNCT01891864What this trial is testingStudy to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and EnbrelWho this might be right forChronic Stable Plaque Psoriasis Sandoz 531
Testing effectiveness (Phase 2)Study completedNCT00820950What this trial is testingRuxolitinib Phosphate Cream When Applied to Patients With Plaque PsoriasisWho this might be right forPsoriasis Incyte Corporation 29
Early research (Phase 1)Study completedNCT00816517What this trial is testingUse of Botulinum Toxin to Treat PsoriasisWho this might be right forPsoriasis Vulgaris University of Minnesota 8
Testing effectiveness (Phase 2)UnknownNCT02112097What this trial is testingASIS for Enbrel in Plaque PsoriasisWho this might be right forPlaque Psoriasis. ASIS Corporation 60
Not applicableStudy completedNCT04922840What this trial is testingImproved Cardiovascular Health for Patients With Inflammatory Joint DiseasesWho this might be right forSpondyloarthritisRheumatoid ArthritisPsoriatic Arthritis Diakonhjemmet Hospital 60
Large-scale testing (Phase 3)Study completedNCT02513550What this trial is testingA Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque PsoriasisWho this might be right forPlaque Psoriasis Eli Lilly and Company 1,257
Not applicableLooking for participantsNCT06100991What this trial is testingCorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness RegistryWho this might be right forGeneralized Pustular Psoriasis CorEvitas 200
Testing effectiveness (Phase 2)Study completedNCT03230292What this trial is testingEvaluate the Long-term Safety, Tolerability and Efficacy of Bimekizumab in Adult Patients With Chronic Plaque PsoriasisWho this might be right forChronic Plaque Psoriasis UCB Biopharma SRL 43
Testing effectiveness (Phase 2)Study completedNCT03069144What this trial is testingEfficacy and Tolerability of HAT1 Compared to Calcipotriol in Patients With Mild to Moderate Chronic Plaque PsoriasisWho this might be right forPsoriasisPsoriasis Vulgaris Haus Bioceuticals 28
Large-scale testing (Phase 3)Study completedNCT04967508What this trial is testingCompare SB17 (Proposed Ustekinumab Biosimilar) to Stelara® in Subject With Moderate to Severe Plaque PsoriasisWho this might be right forPsoriasisModerate to Severe Plaque Psoriasis Samsung Bioepis Co., Ltd. 503
Testing effectiveness (Phase 2)Study completedNCT00585650What this trial is testingStudy of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or FeetWho this might be right forPsoriasis University of California, Irvine 20
Not applicableUnknownNCT03152396What this trial is testingPharmacist CVD Intervention for Patients With Inflammatory ArthritisWho this might be right forInflammatory ArthritisCardiovascular Risk FactorRheumatoid Arthritis+2 more Epidemiology Coordinating and Research Centre, Canada 100